DUBLIN--(BUSINESS WIRE)--The "Generic Injectables Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.
The global generic injectable market is expected to grow at a CAGR of around 7.8% during 2023-2030. This report on global generic injectable market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape.
The report presents a clear picture of the global generic injectable market by segmenting the market based on therapeutic area, containers, distribution channel, and region. Also, detailed profiles of companies operating in the generic injectable market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
- Government Taking Initiatives to Support Manufacture in Various Countries
- Aging Population and Rising Prevalence of Chronic Diseases
- Cheaper and Shorter R&D
Market Challenges
- Contamination Concerns for Injectable Manufactured in Factories in Some Countries
Historical & Forecast Period
- Base Year: 2022
- Historical Period: 2018-2022
- Forecast Period: 2023-2030
Market by Therapeutic Area
- Oncology
- Anaesthesia
- Anti-infective
- Parenteral Nutrition
- Cardiovascular Diseases
Market by Containers
- Vials
- Ampoules
- Premix
- Prefilled Syringes
Market by Distribution Channel
- Hospitals
- Retail Pharmacy
Market by Region
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- Turkey
- Iran
-
Rest of Middle East & Africa
Key Topics Covered:
1. Preface
2. Key Insights
3. Global Generic Injectable Market
4. Global Generic Injectable Market Analysis
5. Global Generic Injectable Market by Therapeutic Area
6. Global Generic Injectable Market by Containers
7. Global Generic Injectable Market by Distribution Channel
8. Global Generic Injectable Market by Region
9. SWOT Analysis
10. Porter's Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
Companies Mentioned
- Hospira (Pfizer)
- Fresenius Kabi
- Hikma Pharma PLC
- Sandoz (Novartis)
- Sagent Inc.
- Sanofi
- Baxter
- Dr. Reddy Laboratories
- Akorn Inc.
- Fresenius SE & Co. KGaA
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd
- Lupin Ltd
- Aurobindo Pharma
- Biocon
For more information about this report visit https://www.researchandmarkets.com/r/wngwix
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
